February 2021

Volume 21 Issue 2

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
EP lab industry representatives are invaluable to hospitals and patients. Let’s consider them frontline health care workers and help them get vaccinated soon.
Patients with leadless PM following TAVI may have shorter hospital stays, and clinical outcomes can be comparable with DDD-PMs. Leadless PMs may therefore be a reasonable option for frail TAVI patients.
EP Lab Digest speaks with electrophysiologist Venkata Bavikati, MD, MPH about the new Heart Rhythm Clinic at Tallahassee Memorial HealthCare.
Senthil Thambidorai, MD and colleagues describe a patient with difficult LAA anatomy that was overcome using the WATCHMAN FLX, when the older-generation device could not be implanted.
EP Lab Digest talks with Nazem Akoum, MD, MS, FACC, FAHA, FHRS about his EP program in Seattle, Washington.
Venkat N. Tholakanahalli, MD, FHRS and colleagues present 2 cases involving the Marshall bundle with demonstration of pure macroreentrant circuit and combination of macro and localized reentrant circuits.
Mariam Bonyadi Camacho, PhD and colleagues review the pathophysiology of COVID-19-induced cardiac injury through both direct and indirect mechanisms, and highlight the therapeutic role of existing cardioprotective interventions.